Profit Margin (Quarterly) Chart

View Profit Margin (Quarterly) for QGEN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Profit Margin (Quarterly) Chart
Start Trial

Historical Profit Margin (Quarterly) Data

View and export this data back to 1999. Start Trial.
Date Value
March 31, 2026 13.82%
December 31, 2025 19.95%
September 30, 2025 24.42%
June 30, 2025 18.04%
March 31, 2025 18.77%
December 31, 2024 16.95%
September 30, 2024 19.54%
June 30, 2024 -36.96%
March 31, 2024 17.58%
December 31, 2023 19.18%
September 30, 2023 16.35%
June 30, 2023 16.33%
March 31, 2023 17.52%
December 31, 2022 17.84%
September 30, 2022 16.49%
June 30, 2022 18.75%
March 31, 2022 24.72%
December 31, 2021 22.18%
September 30, 2021 24.90%
June 30, 2021 21.34%
March 31, 2021 22.78%
December 31, 2020 37.23%
September 30, 2020 3.50%
June 30, 2020 20.25%
March 31, 2020 10.70%
Date Value
December 31, 2019 10.87%
September 30, 2019 -41.98%
June 30, 2019 11.72%
March 31, 2019 8.47%
December 31, 2018 15.12%
September 30, 2018 15.96%
June 30, 2018 9.76%
March 31, 2018 9.40%
December 31, 2017 -10.00%
September 30, 2017 13.32%
June 30, 2017 4.00%
March 31, 2017 5.74%
December 31, 2016 2.35%
September 30, 2016 9.95%
June 30, 2016 6.36%
March 31, 2016 5.25%
December 31, 2015 13.88%
September 30, 2015 10.81%
June 30, 2015 7.86%
March 31, 2015 6.49%
December 31, 2014 7.23%
September 30, 2014 10.35%
June 30, 2014 9.99%
March 31, 2014 7.34%
December 31, 2013 16.61%

Profit Margin Definition

Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.

Read full definition.

Profit Margin (Quarterly) Range, Past 5 Years

View Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Profit Margin (Quarterly) Benchmarks

View Profit Margin (Quarterly) Benchmarks
Start Trial
Thermo Fisher Scientific, Inc. 15.05%
Illumina, Inc. 12.28%
Agilent Technologies, Inc. 18.47%
Bruker Corp. 1.91%
Bio-Rad Laboratories, Inc. -89.02%